| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP2819699 | Oct 16, 2024 | Controlled Release Compositions And Their Methods Of Use | BAYER NEW ZEALAND LIMITED |
| EP2571517 | Oct 16, 2024 | Long - Acting Formulations Of Insulins | SANOFI |
| EP3218406 | Oct 2, 2024 | Binding Molecules Specific For Cd73 And Uses Thereof | MEDIMMUNE LIMITED |
| EP3506884 | Sep 25, 2024 | Drug Delivery Compositions And Uses Thereof | DANA-FARBER CANCER INSTITUTE, INC. |
| EP3236939 | Aug 28, 2024 | Botulinum Toxin Prefilled Container | MERZ PHARMA GMBH & CO. KGAA |
| EP2676679 | Aug 28, 2024 | Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions | WYETH LLC |
| EP3076983 | Aug 14, 2024 | Ionic Aqueous Compositions | GEROLYMATOS INTERNATIONAL S.A. |
| EP2687103 | Jul 24, 2024 | Aqueous Transparent Oil-In-Water Emulsion Comprising An Emulsified Carotenoid | BASF SE |
| EP3296395 | Jun 19, 2024 | Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| EP1962797 | May 29, 2024 | Powder Compositions For Inhalation | JAGOTEC AG |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP2345410 | Dec 30, 2020 | Controlled Release Pharmaceutical Composition | ASTELLAS PHARMA INC. | 60 |
| EP3463360 | Aug 31, 2022 | Atropine Containing Aqueous Composition | NANYANG TECHNOLOGICAL UNIVERSITY | 36 |
| EP2793833 | Jun 24, 2020 | Topical Oil Composition For The Treatment Of Fungal Infections | VYOME THERAPEUTICS LIMITED | 30 |
| EP2059232 | Apr 19, 2017 | Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin | ALFASIGMA S.P.A. | 24 |
| EP3570884 | Sep 30, 2020 | Subcutaneous Her2 Antibody Formulations | F. HOFFMANN-LA ROCHE AG | 24 |
| EP1687019 | Nov 22, 2017 | Propylene Glycol Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices | NOVO NORDISK A/S | 24 |
| EP1957110 | Dec 23, 2020 | Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products Thereof | BAYER HEALTHCARE, LLC | 21 |
| EP3300721 | Mar 6, 2019 | Propylene Glycol Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices | NOVO NORDISK A/S | 20 |
| EP2874624 | Oct 2, 2019 | Injectable Antibiotic Formulations And Their Methods Of Use | BAYER NEW ZEALAND LIMITED | 20 |
| EP3714877 | Jan 26, 2022 | Method And Composition For Treating Ocular Hypertension And Glaucoma | SANTEN PHARMACEUTICAL CO., LTD. | 18 |
Feel free to send us a message here and we will get back to you